Denver Colorado, Oct. 8, 2013 (GLOBE NEWSWIRE) -- FusionPharm, Inc, (OTC SYMBOL) FSPM (www.fusionpharminc.com), the Denver based manufacturer of the PharmPods™ cultivation system (www.pharmpods.com) is pleased to let shareholders and interested parties know that it is being featured in an interview on "The Stock Radio". In the interview, company CEO Scott Dittman can be heard discussing the company's new manufacturing and sales facility as well as the company's direction for the next twelve to eighteen months. The interview can be heard at http://thestockradio.com/fspm-fusion-pharm-inc-ceo-scott-dittman/
About FusionPharm Inc. (FSPM)
FusionPharm, Inc. (FSPM) (www.fusionpharminc.com) was organized to capitalize on opportunities present in the rapidly growing vertical farming and cannabis industries. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods™ advanced hydroponic commercial cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor controlled environment agriculture. Modular, stackable, cost competitive and financeable, PharmPods have become the industry leader for professional, commercial scale indoor plant cultivation.
TheStockRadio is a small-cap research and investment commentary provider. TheStockRadio.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on TheStockRadio please visit http://thestockradio.com
TheStockRadio.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. This website is a service of Seo Freisin Inc. Please read our report and visit our Web site, http://thestockradio.com for complete Disclaimer and disclosures.
NOTES ABOUT FORWARD-LOOKING STATEMENTS: Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.
CONTACT: firstname.lastname@example.org Source:FusionPharm, Inc.